Halozyme Therapeutics (HALO) Share-based Compensation (2010 - 2026)
Halozyme Therapeutics' Share-based Compensation was $17.7 million in Q2 2026, up 45.5% from $12.16 million a year earlier and up 6.4% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Halozyme Therapeutics' Share-based Compensation was $63.07 million through Jun 30, 2026, up 34.5% year-over-year; for FY2025, it was $51.57 million, up 18.9% from FY2024.
- Share-based Compensation has now increased for five consecutive years, with a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $43.39 million in FY2024 (+18.5%), $36.62 million in FY2023 (+50.1%), $24.4 million in FY2022 (+17.2%) and $20.82 million in FY2021 (+21.0%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
- Compared with a year earlier, Share-based Compensation has increased for three straight quarters, with growth averaging 29.0% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2023 (growth of 70.8%); the worst was Q1 2022 (a decline of 3.7%).
- Per Business Quant data, HALO's Share-based Compensation in the three quarters before Q2 2026 was $16.64 million (Q1 2026), $16.57 million (Q4 2025) and $12.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 17.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.70 Mn |
| Mar 31, 2026 | 16.64 Mn |
| Dec 31, 2025 | 16.57 Mn |
| Sep 30, 2025 | 12.16 Mn |
| Jun 30, 2025 | 12.16 Mn |
| Mar 31, 2025 | 10.67 Mn |
| Dec 31, 2024 | 11.46 Mn |
| Sep 30, 2024 | 12.58 Mn |
| Jun 30, 2024 | 9.47 Mn |
| Mar 31, 2024 | 9.87 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Sep 30, 2023 | 9.37 Mn |
| Jun 30, 2023 | 9.62 Mn |
| Mar 31, 2023 | 7.97 Mn |
| Dec 31, 2022 | 7.22 Mn |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 5.64 Mn |
| Mar 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | 5.13 Mn |
| Sep 30, 2021 | 5.40 Mn |
API Access
Halozyme Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();